Category Archives: Biotech

The Skinny On The Spider Goat

Although I just heard about the Spider Goat story yesterday for the first time, it turns out that Forbes had written a full story on it over a year ago. ABC News also covered the story in detail a while back.

(And here’s the poop straight from the source at Nexia Biotech.)

Here’s the Forbes story by Christopher Helman:
Charlotte’s Goat.

Nexia is tackling a materials-science conundrum that has stumped even DuPont for 20 years: how to synthesize spider silk. Milking the spiders themselves is out of the question

Seeding Good Feelings Towards Genetically-altered Food

Some agricultural biotechnology interests (Monsanto and Syngenta) have found a new humanitarian ways of dodging the real concerns surrounding the use of biogenetically-altered plants in food crops.

See:
Cultivating a New Image: Firms Give Away Data, Patent Rights on Crops,
by Justin Gillis for the Washington Post.

But the long-term environmental impact of the crops remains a serious question. Many scientists wonder whether foreign genes inserted into crops can spread to the wild relatives of those plants, doing some kind of unforeseen environmental damage.

In fact, several incidents have suggested that the ag bio companies, whatever their intentions, won’t be able to control where their altered genes wind up. Agricultural biotechnology’s biggest debacle to date occurred when an altered crop called Starlink corn, approved only for use as animal food, turned up in the human food supply, forcing widespread recalls of taco shells and other products.

That mess forced all the biotechnology companies to pledge never to put a crop on the market for animal use only, because it would be certain to wind up in the human food supply. For similar reasons, many American farmers are worried about Monsanto’s efforts to commercialize a genetically engineered wheat. The farmers, though they may support biotechnology in principle, are afraid the altered wheat will taint the entire American crop in the eyes of foreign buyers.

New Cancer Biomarkers

A breakthrough in biomarkers was revealed at an oncology conference last week in San Francisco. See:
New biomarkers for ovarian, breast, and head and neck cancers identified.

Researchers have identified new biomarkers for ovarian, breast, and head and neck cancers that could lead to earlier detection of these malignancies and improved treatment outcomes, according to study findings presented this week at a major oncology meeting in San Francisco.